))
Episode 16: Antibiotic Resistance: The Patient Experience
Manage episode 337444518 series 3381207
Treść dostarczona przez Gunnar Esiason. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Gunnar Esiason lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
The State of Health is back after a brief summer vacation. This week, Emma D'Agostino, PhD joins the show to talk with Gunnar about their jointly written opinion piece that appeared in The Hill in mid-August entitled: New bipartisan legislation can encourage needed antibiotic development, where they called for bipartisan reform of the antibiotic market. Gunnar and Emma lean on past personal experience with antibiotic resistant infections, their frustrations with the lack of new options and their hopes for how policymakers can reach across the aisle to address the broken incentives at the heart of the reimbursement market that is largely specific to antibiotics.
The episode is the first in an ongoing series about antibiotics and the quest to bring novel technologies to combat the rising threat of antimicrobial resistance.
To learn more about listener data and our privacy practices visit: https://www.audacyinc.com/privacy-policy
Learn more about your ad choices. Visit https://podcastchoices.com/adchoices
23 odcinków
Udostępnij
